Functional dissection of the transactivation domain of interferon regulatory factor-1

Biochemical and Biophysical Research Communications

Volumn 304, Issue 2, 2003, Pages 253-259

  Kim, Eun Joo ^a,b,d   Park, Chong Ho ^a   Park, Jong Sup ^b,c   Um, Soo Jong ^a  

^a Sejong University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Activation domain; Deletion mutant; FACS; In situ gal staining; Interferon regulatory factor 1; Transactivation

Indexed keywords

BETA GALACTOSIDASE; CASEIN KINASE II; COMPLEMENTARY DNA; INTERFERON REGULATORY FACTOR 1; PROTEIN KINASE C;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DELETION MUTANT; ENZYME ACTIVE SITE; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; STAINING; TRANSACTIVATION;

EID: 0037414467     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00575-8     Document Type: Article

References (22)

1. Taniguchi T., Lamphier M.S., Tanaka N. IRF-1: the transcription factor linking the interferon response and oncogenesis. Biochim. Biophys. Acta. 1333:1997;M9-17.
2. Kroger A., Koster M., Schroeder K., Hauser H., Mueller P.P. Activities of IRF-1. J. Interferon Cytokine Res. 22:2002;5-14.
3. Romeo G., Fiorucci G., Chiantore M.V., Percario Z.A., Vannucchi S., Affabris E. IRF-1 as a negative regulator of cell proliferation. J. Interferon Cytokine Res. 22:2002;39-47.
4. Willman C.L., Sever C.E., Pallavicini M.G., Harada H., Tanaka N., Slovak M.L., Yamamoto H., Harada K., Meeker T.C., List A.F., Taniguchi T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science. 259:1993;968-971.
5. Tanaka N., Ishihara M., Kitagawa M., Harada H., Kimura T., Matsuyama T., Lamphier M.S., Aizawa S., Mak T.W., Taniguchi T. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell. 77:1994;829-839.
6. Nozawa H., Oda E., Nakao K., Ishihara M., Ueda S., Yokochi T., Ogasawara K., Nakatsuru Y., Shimizu S., Ohira Y., Hioki K., Aizawa S., Ishikawa T., Katsuki M., Muto T., Taniguchi T., Tanaka N. Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53. Genes Dev. 13:1999;1240-1245.
7. Tamura T., Ishihara M., Lamphier M.S., Tanaka N., Oishi I., Aizawa S., Matsuyama T., Mak T.W., Taki S., Taniguchi T. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature. 376:1995;596-599.
8. Kano A., Haruyama T., Akaike T., Watanabe Y. IRF-1 is an essential mediator in IFN-γ-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. Biochem. Biophys. Res. Commun. 257:1999;672-677.
9. Kim E.J., Lee J.M., Namkoong S.E., Um S.J., Park J.S. Interferon regulatory factor-1 mediates interferon-γ-induced apoptosis in ovarian carcinoma cells. J. Cell. Biochem. 85:2002;369-380.
10. Tanaka N., Ishihara M., Lamphier M.S., Nozawa H., Matsuyama T., Mak T.W., Aizawa S., Tokino T., Oren M., Taniguchi T. Cooperation of the tumor suppressors IRF-1 and p53 in response to DNA damage. Nature. 382:1996;816-818.
11. Um S.J., Kim E.J., Hwang E.S., Kim S.J., Namkoong S.E., Park J.S. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53. Int. J. Cancer. 85:2000;416-423.
12. Prost S., Bellamy C.O., Cunningham D.S., Harrison D.J. Altered DNA repair and dysregulation of p53 in IRF-1 null hepatocytes. FASEB J. 12:1998;181-188.
13. Mamane Y., Heylbroeck C., Genin P., Algarte M., Servant M.J., LePage C., DeLuca C., Kwon H., Lin R., Hiscott J. Interferon regulatory factors: the next generation. Gene. 237:1999;1-14.
14. Escalante C.R., Yie J., Thanos D., Aggarwal A.K. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature. 391:1998;103-106.
15. Lin R., Mustafa A., Nguyen H., Gewert D., Hiscott J. Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-β gene expression. J. Biol. Chem. 269:1994;17542-17549.
16. Schaper F., Kirchhoff S., Posern G., Koster M., Oumard A., Sharf R., Levi B.Z., Hauser H. Functional domains of interferon regulatory factor I (IRF-1). Biochem. J. 335:1998;147-157.
17. Kirchhoff S., Oumard A., Nourbakhsh M., Levi B.Z., Hauser H. Interplay between repressing and activating domains defines the transcriptional activity of IRF-1. Eur. J. Biochem. 267:2000;6753-6761.
18. Eroshkin A., Mushegian A. Conserved transactivation domain shared by interferon regulatory factors and Smad morphogens. J. Mol. Med. 77:1999;403-405.
19. Park J.S., Kim E.J., Kwon H.J., Hwang E.S., Namkoong S.E., Um S.J. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J. Biol. Chem. 275:2000;6764-6769.
20. Rose M.D., Winston F., Hieter P. Methods in Yeast Genetics: A Laboratory Course Manual. 1990;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Rost B. PHD: predicting one-dimensional protein structure by profile-based neural networks. Methods Enzymol. 266:1996;525-539.
22. Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., Taniguchi T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 58:1989;729-739.